A preeclampsia-like syndrome has recently been found in severe COVID-19 pregnancies based on differences in angiogenic factors such as the ratio of the soluble fms-like tyrosine kinase-1 and placental growth factor (sFlt-1/PlGF) [32]. Here, FLT1 is linked to COVID-19.